Cellromax Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	May '26 May 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	55,425	73,574	57,231
Market Cap Growth	-10.70%	28.56%	-
Enterprise Value	48,199	68,367	-
Last Close Price	5020.00	6435.26	4704.43
PE Ratio	19.23	24.80	14.99
PS Ratio	2.50	3.32	2.65
PB Ratio	1.18	1.57	1.29
P/TBV Ratio	1.26	1.67	1.39
P/FCF Ratio	32.47	43.11	9.40
P/OCF Ratio	31.04	41.21	9.09
EV/Sales Ratio	2.17	3.08	-
EV/EBITDA Ratio	14.54	20.63	-
EV/EBIT Ratio	17.00	24.11	-
EV/FCF Ratio	28.24	40.06	-
Debt / Equity Ratio	0.01	0.01	0.03
Debt / EBITDA Ratio	0.14	0.14	0.25
Debt / FCF Ratio	0.28	0.28	0.25
Net Debt / Equity Ratio	-0.15	-0.15	-0.48
Net Debt / EBITDA Ratio	-2.18	-2.18	-3.58
Net Debt / FCF Ratio	-4.23	-4.23	-3.49
Asset Turnover	0.44	0.44	-
Inventory Turnover	2.14	2.14	-
Quick Ratio	3.08	3.08	7.41
Current Ratio	5.20	5.20	9.10
Return on Equity (ROE)	6.49%	6.49%	-
Return on Assets (ROA)	3.54%	3.54%	-
Return on Invested Capital (ROIC)	6.27%	7.74%	17.55%
Return on Capital Employed (ROCE)	5.90%	5.90%	12.00%
Earnings Yield	5.35%	4.03%	6.67%
FCF Yield	3.08%	2.32%	10.64%
Payout Ratio	90.04%	114.25%	-
Buyback Yield / Dilution	-9.27%	-9.27%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.